Charles P. Perlia
- Physiology top 1%
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Nutrition and Dietetics top 2%
- Co-authors
- John HortonWilliam D. DeWysDouglass C. TormeyPierre R. BandEdiz Z. EzdinliJohn M. BennettMurray N. SilversteinCharles G. Moertel
- Topics
- Bone health and treatments (4 papers)Cancer Genomics and Diagnostics (4 papers)Lung Cancer Treatments and Mutations (4 papers)
- Partner nations
- United StatesCanadaMalaysia
In The Last Decade
Charles P. Perlia
25 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Physiology 1.4k
- Oncology 806
- Molecular Biology 449
- Pulmonary and Respiratory Medicine 427
- Nutrition and Dietetics 417
Countries citing papers authored by Charles P. Perlia
This map shows the geographic impact of Charles P. Perlia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles P. Perlia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles P. Perlia more than expected).
Fields of papers citing papers by Charles P. Perlia
This network shows the impact of papers produced by Charles P. Perlia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles P. Perlia. The network helps show where Charles P. Perlia may publish in the future.
Co-authorship network of co-authors of Charles P. Perlia
This figure shows the co-authorship network connecting the top 25 collaborators of Charles P. Perlia. A scholar is included among the top collaborators of Charles P. Perlia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles P. Perlia. Charles P. Perlia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 95 | |
| 3 | Prognostic effect of weight loss prior tochemotherapy in cancer patientsbreakdown → | 1785 |
| 4 | Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung. | 4 |
| 5 | Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. | 57 |
| 6 | Adriamycin in the treatment of far-advanced lung cancer. | 15 |
| 7 | 21 | |
| 8 | 3 | |
| 9 | 9 | |
| 10 | 17 | |
| 11 | 3 | |
| 12 | 59 | |
| 13 | 41 | |
| 14 | 129 | |
| 15 | 54 | |
| 16 | 4 | |
| 17 | 28 | |
| 18 | 20 | |
| 19 | 2 | |
| 20 | [ACTH-cortisone and tuberculosis]. | 0 |
About Charles P. Perlia
Charles P. Perlia is a scholar working on Oncology, Cancer Research and Neurology, having authored 26 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bone health and treatments (4 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Geriatrics and Gerontology (351 citations), Physiology (1.4k citations) and Oncology (806 citations). Charles P. Perlia has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include John Horton, William D. DeWys, Douglass C. Tormey, Pierre R. Band, Ediz Z. Ezdinli, John M. Bennett, Murray N. Silverstein, Charles G. Moertel, Colin B. Begg and Harold O. Douglass. Their work appears in journals such as Annals of Internal Medicine, The Journal of Clinical Endocrinology & Metabolism and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.